APA (7th ed.) Citation

S, O., S, Y., K, O., Y, A., M, M., & D, A. (2026). Activity of Ponatinib and Vitamin K2 Against Myelodysplastic Syndrome and Acute Myeloid Leukemia Cells. Anticancer research, 46(3), 1247. https://doi.org/10.21873/anticanres.18026

Chicago Style (17th ed.) Citation

S, Okabe, Yoshizawa S, Osone K, Arai Y, Moriyama M, and Akahane D. "Activity of Ponatinib and Vitamin K2 Against Myelodysplastic Syndrome and Acute Myeloid Leukemia Cells." Anticancer Research 46, no. 3 (2026): 1247. https://doi.org/10.21873/anticanres.18026.

MLA (9th ed.) Citation

S, Okabe, et al. "Activity of Ponatinib and Vitamin K2 Against Myelodysplastic Syndrome and Acute Myeloid Leukemia Cells." Anticancer Research, vol. 46, no. 3, 2026, p. 1247, https://doi.org/10.21873/anticanres.18026.